24 May 2018 - - Baltimore, Maryland-based urological medicine organization the American Urological Association (AUA), at the 113th Annual Scientific Meeting of the American Urological Association, has presented data from three studies indicating that a multifaceted approach to treating men with orchialgia and chronic pelvic pain may lead to improvements in quality of life and less pain over time, the organization said.
In an assessment of trigger point dry needling as a treatment for orchialgia, an analysis of self-reported improvement data from 2009 to 2016, as well as NIH Chronic Prostatitis Symptom Index (NIH-CPSI) data, showed that 85% of patients who underwent pelvic floor trigger point dry needling as a component of physical therapy (PT) indicated their orchialgia improved.
To evaluate the benefit of physical therapy for orchialgia in previously treated patients, researchers conducted a retrospective review of patient data for men who underwent pelvic floor PT after going through other treatments, including non-steroidal anti-inflammatory drugs, antibiotics, surgery, nerve block, narcotics, and previous pelvic floor PT. Results showed an improvement in NIH-CPSI pain and quality of life categories for all patients who received previous orchialgia treatment.
A randomised controlled study of 108 patients with prostatitis, but without erectile dysfunction, evaluated the efficacy and safety of a daily low dose tadalafil added to levofloxacin for the treatment of chronic prostatitis/chronic pelvic pain syndrome.
The study concluded low dose tadalafil added to levofloxacin as treatment is well tolerated and significantly improved chronic prostatitis/chronic pelvic pain syndrome related symptoms.
The AUA, an advocate for the specialty of urology, has more than 21,000 members throughout the world. The association encourages scientific research, education and formulation of health care policy in the field of urologic medicine.